CROS NT appoints MacGarvey as vice president

Wednesday, August 15, 2012 02:01 PM

CROS NT, an international CRO specializing in clinical data services, has appointed Andrew MacGarvey as the vice president of U.K. and U.S. operations.

MacGarvey brings for CROS NT 15 years experience in the pharmaceutical sector. With a strong background in programming and data management, he has worked in senior management and director roles for multiple CROs in Europe and the U.S. MacGarvey has experience in growing U.K.‐based operations, as well as establishing U.S. offices.

MacGarvey’s promotion comes as CROS NT expands into the U.K. by establishing CROS NT Limited and opening office space in Atterbury Lakes Business Park in Milton Keynes, just north of London.

 

 

Share:          
CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs